Repligen
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.
| Company type | Public company |
|---|---|
| Nasdaq: RGEN S&P 400 Component | |
| Industry | Pharmaceutical industry |
| Founded | 1981 |
| Founders | Alexander Rich Paul Schimmel |
| Headquarters | Waltham, Massachusetts , United States |
Key people | Tony J. Hunt (President) and CEO) |
| Products | Materials used in the manufacture of biological drugs |
| Revenue | US$68 million (2014) |
| US$23 million (2014) | |
| Total assets | US$119 million (2014) |
| Total equity | US$104 million (2014) |
Number of employees | 116 (2014) |
| Website | www |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.